TBXA2R activates ERMs to drive motility, invasion, and metastatic colonization of TNBC cells
Life Science Alliance · 2026-06 · 9 (6) · e202503601
DOI: 10.26508/lsa.202503601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 17.03.2026. Verfasst von Kévin Leguay und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Canada leguay.kevin@gmail.com. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Cytoskeletal Proteins, Microfilament Proteins, Membrane Proteins. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, Cancer Research Society, FRQ | Santé.
Abstract (Originalsprache)
Cell migration and invasion are critical for cancer cell metastasis, relying on the ability of cells to adapt their morphology. Proteins of the ezrin, radixin, and moesin (ERM) family are key regulators of cell morphogenesis and essential determinants of cancer cell metastasis. However, the mechanisms by which ERMs are activated in metastatic cells remain poorly understood. We identified the thromboxane A2 receptor (TBXA2R), a G protein–coupled receptor overexpressed in multiple cancers, as a critical activator of ERMs, enhancing the motility and invasion of triple-negative breast cancer cells. We found that TBXA2R activates ERMs by engaging the Gα q/11 and Gα 12/13 subfamilies, the Rho subfamily of Rho GTPases, and their Ser/Thr kinase effectors SLK and LOK. Furthermore, we demonstrate that TBXA2R promotes triple-negative breast cancer cell motility and invasion in vitro and metastatic colonization in vivo, dependent on ERM function. This reveals a novel signaling axis by which a member of the largest class of receptors activates key metastatic determinants, thereby controlling various aspects of metastasis. This discovery opens new avenues for developing targeted therapies against cancer metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Canada leguay.kevin@gmail.com.
- Cellular Mechanisms of Morphogenesis During Mitosis and Cell Motility Lab, Montréal, Canada.
- Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, Canada.
- Molecular Pharmacology Lab, Montréal, Canada.
- Signaling and Cell Growth Lab, Montréal, Canada.
- Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Canada.
ORCID-Profile: Kévin Leguay, Sylvain Meloche, Michel Bouvier, Sébastien Carréno
Förderung
- Canadian Institutes of Health Research
- Cancer Research Society
- FRQ | Santé
Zitieren
APA
Leguay, K., Naffati, O., Kiyan, C. L., He, Y. Y., Hogue, M., Tesnière, C., Gombos, M., Kuasne, H., Gaboury, L., Le Gouill, C., Meloche, S., Bouvier, M., & Carréno, S. (2026). TBXA2R activates ERMs to drive motility, invasion, and metastatic colonization of TNBC cells. Life Science Alliance, 9(6), e202503601. https://doi.org/10.26508/lsa.202503601
Vancouver
Leguay K, Naffati O, Kiyan CL, He YY, Hogue M, Tesnière C, et al. TBXA2R activates ERMs to drive motility, invasion, and metastatic colonization of TNBC cells. Life Science Alliance. 2026;9(6):e202503601. doi:10.26508/lsa.202503601
BibTeX
@article{Leguay2026,
author = {Leguay, Kévin and Naffati, Omaima and Kiyan, Camila Lie and He, Yu Yan and Hogue, Mireille and Tesnière, Chloé and Gombos, Melania and Kuasne, Hellen and Gaboury, Louis and Le Gouill, Christian and Meloche, Sylvain and Bouvier, Michel and Carréno, Sébastien},
title = {TBXA2R activates ERMs to drive motility, invasion, and metastatic colonization of TNBC cells},
journal = {Life Science Alliance},
year = {2026},
volume = {9},
number = {6},
pages = {e202503601},
doi = {10.26508/lsa.202503601}
}
EUVIMED